Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer
- PMID: 38869820
- DOI: 10.1007/s12029-024-01069-9
Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer
Abstract
Purpose: This study aimed to evaluate the clinicopathological and prognostic significance of preoperative serum creatine kinase (CK) levels in colorectal cancer.
Methods: This study analyzed 1169 patients with colorectal cancer at stages 0 (n = 35), I (n = 301), II (n = 456), III (n = 339), and IV (n = 38). The CK cut-off value was 52 U/L to predict recurrence based on receiver operative characteristics curve. Clinicopathological factors were compared between the low (< 52 U/L) and high CK groups (≥ 52 U/L). The multivariate analysis evaluated relapse-free survival (RFS) and overall survival (OS) following CK status.
Results: The female sex, elderly age (≥ 75), deep tumor (pT4), and carcinoembryonic antigen (+) were independently associated with low CK status. The recurrent rate was significantly higher in the low CK group than in the high CK group (19.1% vs. 11.7%, p < 0.001). Elderly age, pT4, pN (+), preoperative carbohydrate antigen (CA) 19-9 (+), and low CK status were independent risk factors for RFS. Elderly age, pT4, pN (+), preoperative CA19-9 (+), and low CK status were independent risk factors for OS.
Conclusion: Preoperative low CK status was associated with deep tumors and was a poor prognostic factor in patients with colorectal cancer.
Keywords: Colorectal cancer; Creatine kinase; OS; RFS.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.Eur J Surg Oncol. 2021 Nov;47(11):2880-2887. doi: 10.1016/j.ejso.2021.05.041. Epub 2021 Jun 2. Eur J Surg Oncol. 2021. PMID: 34103245
-
Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.Asian Pac J Cancer Prev. 2011;12(5):1251-6. Asian Pac J Cancer Prev. 2011. PMID: 21875276
-
An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.Colorectal Dis. 2015 May;17(5):417-25. doi: 10.1111/codi.12865. Colorectal Dis. 2015. PMID: 25512077
-
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.Int J Clin Oncol. 2020 Apr;25(4):622-632. doi: 10.1007/s10147-019-01597-6. Epub 2019 Dec 9. Int J Clin Oncol. 2020. PMID: 31820210
-
Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.J Surg Res. 2016 Oct;205(2):384-392. doi: 10.1016/j.jss.2016.06.078. Epub 2016 Jul 4. J Surg Res. 2016. PMID: 27664887
Cited by
-
It Is Not Just About Storing Energy: The Multifaceted Role of Creatine Metabolism on Cancer Biology and Immunology.Int J Mol Sci. 2024 Dec 11;25(24):13273. doi: 10.3390/ijms252413273. Int J Mol Sci. 2024. PMID: 39769038 Free PMC article. Review.
References
-
- Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3D english edition [secondary publication]. J Anus Rectum Colon. 2019;3:175–95. https://doi.org/10.23922/jarc.2019-018 . - DOI - PMC
-
- Ushigome M, Shimada H, Miura Y, Nagashima Y, Suzuki T, Kagami S, Kurihara A, Funahashi K. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA. Int J Clin Oncol. 2020;25:622–32. https://doi.org/10.1007/s10147-019-01597-6 . Epub 2019 Dec 9 PMID: 31820210. - DOI - PubMed
-
- Suzuki S, Akiyoshi T, Oba K, Oba K, Otsuka F, Tominaga T, Nagasaki T, Fukunaga Y, Ueno M. Comprehensive comparative analysis of prognostic value of systemic inflammatory biomarkers for patients with stage II/III colon cancer. Ann Surg Oncol. 2020;27:844–52. https://doi.org/10.1245/s10434-019-07904-9 . Epub 2019 Nov 12 PMID: 31720937. - DOI - PubMed
-
- Ishikawa S, Miyoshi N, Fujino S, Fujino S, Ogino T, Takahashi H, Uemura M, Yamamoto H, Mizushima T, Doki Y, Eguchi H. Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0-III colorectal cancer after curative resection. Ann Gastroenterol Surg. 2021;2021(5):345–53. https://doi.org/10.1002/ags3.12426.eCollection . PMID: 34095725. - DOI
-
- Okugawa Y, Toiyama Y, Fujikawa H, Kawamura M, Yasuda H, Yokoe T, Mochiki I, Okita Y, Ohi M, Nakatani K. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer. Surg Today. 2021;51:1906–17. https://doi.org/10.1007/s00595-021-02291-9 . Epub 2021 May 5PMID: 33954875. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials